Crystalline ACAT inhibitor
AssigneeGraceway Pharmaceuticals, LLC
InventorRita Mayur Lodaya
Life of this patent
Estimating the term…
Abstract
The invention is directed to the Form A polymorph of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide and its use as a therapeutic/cosmetic agent.
Claims10
Form A polymorph of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide.
A crystalline polymorph of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide that exhibits an X-ray powder diffraction pattern having at least one characteristic peak expressed in degrees 2θ at approximately 16.0, 19.6, or 28.1.
A crystalline polymorph of N-benzyl-N′-(2,6-diisopropyl-phenyl)-N-isopropyl-malonamide that exhibits an X-ray powder diffraction pattern having characteristic peaks expressed in degrees 2θ at approximately 16.0, 19.6, and 28.1.
Dependencies are inferred from the claim text.